Sphingolipids in cancer: regulation of pathogenesis and therapy.
about
Roles of bioactive sphingolipids in cancer biology and therapeuticsCharacterization of isoenzyme-selective inhibitors of human sphingosine kinasesCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2Multiple roles for sphingolipids in steroid hormone biosynthesisClinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasisIdentification of metabolites with anticancer properties by computational metabolomicsCeramide signaling in cancer and stem cells.PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphateThe interplay between bioactive sphingolipids and steroid hormones.miR-31 Links Lipid Metabolism and Cell Apoptosis in Bacteria-Challenged Apostichopus japonicus via Targeting CTRP9.Sphingolipids and expression regulation of genes in cancer.Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport.Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cellsA novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.Potential Application of 1H NMR for Routine Serum Lipidome Analysis -Evaluation of Effects of Bariatric Surgery.Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis.Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
P2860
Q24657499-0F571315-3631-4A87-957D-3E85D1F9FAA9Q28483643-9A201DDC-7DFA-41B8-8F9B-E95AF786C4B9Q33733991-E2CB30F4-D76B-4A88-BA3F-9D09BBCD1855Q33755206-FDE00810-6710-4D12-ACE1-2A34B08F534BQ33923721-26B7D88C-9A11-4D5A-A0C0-9F1BC4D400C2Q36157057-4630D09F-D082-48B9-86AE-5942A8A017E2Q36755528-2A2FD970-CD52-4286-BBD5-AE8B3B73899BQ36803735-7DCD805E-70BA-42EE-B0F8-B48B401B6022Q37131905-8BF5D9D7-4D51-4BE0-B23A-EAF3A8CE0F42Q37688434-B2F899BC-FA83-49AF-8647-A5DDD33730C2Q37694420-24749193-9E7C-44F3-AFFE-692942B48893Q37802552-5499DD12-3B52-4E73-AB4A-93566FE2BA92Q38759745-8C109E06-6406-4655-AA04-8B4001027E85Q39097201-E4EE2B31-4A74-4036-9345-BBA98997264BQ39201102-F7216B0F-075D-4E2A-9E54-1334C2AAF1A5Q39420607-AFD6889D-6A62-4AE1-B48C-B85BFB1799FEQ39485300-BCA147D5-D5FE-4412-98CC-80E1E5735E6DQ39566737-F9E2163D-7596-4566-9455-3F6259779EC1Q43094374-E6FB5247-3911-485E-95C3-FCFEF6AE68F5Q43244413-94729403-56D6-4C50-9D58-7A57BB5AA1E2Q46210843-CC874EFD-ABFB-4C15-BB3A-EC1A147EA0CCQ47096344-01F755C0-28F6-4637-9049-B1571167828AQ47595409-96140CCF-E269-4B63-B03F-B25480ED8C2AQ49399657-39F6A133-C849-497E-99FF-DDF97614B509
P2860
Sphingolipids in cancer: regulation of pathogenesis and therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@ast
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@en
type
label
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@ast
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@en
prefLabel
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@ast
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@en
P2860
P1433
P1476
Sphingolipids in cancer: regulation of pathogenesis and therapy.
@en
P2093
Besim Ogretmen
P2860
P304
P356
10.1016/J.FEBSLET.2006.08.052
P407
P577
2006-09-05T00:00:00Z